Right-sided rhabdoid colorectal tumors might be related to the Serrated Pathway

Diagnostic Pathology

Volumn 8, Issue 1, 2013, Pages

  Pancione, Massimo ^a   Remo, Andrea ^b   Sabatino, Lina ^a   Zanella, Caterina ^b   Votino, Carolina ^a   Fucci, Alessandra ^a   Di Blasi, Arturo ^c   Lepore, Giovanni ^c   Daniele, Bruno ^c   Fenizia, Francesca ^d   Molinari, Enrico ^b   Normanno, Nicola ^d   Manfrin, Erminia ^e   Vendraminelli, Roberto ^b   Colantuoni, Vittorio ^a  

^a UNIVERSITY OF SANNIO   (Italy)

^b ULSS21 ^*  (Italy)

^c G RUMMO HOSPITAL   (Italy)

^d INT Fondazione Pascale CROM   (Italy)

^e UNIVERSITY OF VERONA   (Italy)

Author keywords

CpG island methylator phenotype, CIMP; Rhabdoid Colorectal Tumor, RCT; Serrated pathway

Indexed keywords

B RAF KINASE; BRAF PROTEIN, HUMAN; PARAFFIN; TUMOR MARKER;

ADENOMA; AGED; ARTICLE; CASE REPORT; CHEMISTRY; CHROMOSOME 22; COLORECTAL TUMOR; CPG ISLAND; DISEASE COURSE; DNA METHYLATION; FATALITY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; GENETIC EPIGENESIS; GENETIC PREDISPOSITION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; INTESTINE MUCOSA; MICROSATELLITE INSTABILITY; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHENOTYPE; POLYMERASE CHAIN REACTION; RHABDOID TUMOR; SIGNAL TRANSDUCTION; TIME; TREATMENT OUTCOME;

ADENOMA; AGED; CHROMOSOMES, HUMAN, PAIR 22; COLORECTAL NEOPLASMS; CPG ISLANDS; DISEASE PROGRESSION; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; EPIGENESIS, GENETIC; FATAL OUTCOME; FEMALE; GENE REARRANGEMENT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; INTESTINAL MUCOSA; MICROSATELLITE INSTABILITY; MUTATION; PARAFFIN EMBEDDING; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS B-RAF; RHABDOID TUMOR; SIGNAL TRANSDUCTION; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

MLCS; MLOWN;

EID: 84873954066     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-8-31     Document Type: Article

References (22)

1. Remo A, Zanella C, Molinari E, Talamini A, Tollini F, Piacentini P, Battaglia P, Baritono E, Bonetti A, Lanza F, Fasolin A, Manfrin E, Vendraminelli R. Rhabdoid carcinoma of the colon, a distinct entity with a very aggressive behaviour. A case report, associated with a polyposis coli and review of the literature. Int J Surg Pathol 2012, 20:185-190.
2. Pancione M, Di Blasi A, Sabatino L, Fucci A, Dalena AM, Palombi N, Carotenuto P, Aquino G, Daniele B, Normanno N, Colantuoni V. A novel case of rhabdoid colon carcinoma associated with a positive CpG island methylator phenotype and BRAF mutation. Hum Pathol 2011, 42:1047-1052. 10.1016/j.humpath.2010.10.016, 21315413.
3. Tóth L, Nemes Z, Gomba S, Asztalos L, Molnár C, András C, Szentirmay Z, Molnár P. Primary rhabdoid cancer of the ileum: a case report and review of the literature. Pathol Res Pract 2010, 206:110-115. 10.1016/j.prp.2009.02.013, 19369011.
4. Fletcher C, Unni K, Mertens F. WHO Pathology and Genetics of Tumours of Soft Tissue and Bone 2002, France: Lyon IARC Press.
5. Roberts CW, Biegel JA. The role of SMARCB1/INI1 in development of rhabdoid tumor. Cancer Biol Ther 2009, 8:412-416. 10.4161/cbt.8.5.8019, 2709499, 19305156.
6. Biegel JA, Zhou JY, Rorke LB, Stenstrom C, Wainwright LM, Fogelgren B. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res 1999, 59:74-79.
7. Breault JE, Shiina H, Igawa M, Ribeiro-Filho LA, Deguchi M, Enokida H, Urakami S, Terashima M, Nakagawa M, Kane CJ, Carroll PR, Dahiya R. Methylation of the g-Catenin Gene Is Associated With Poor Prognosis of Renal Cell Carcinoma. Clin Cancer Res 2005, 11:557-564.
8. Pancione M, Sabatino L, Fucci A, Carafa V, Nebbioso A, Forte N, Febbraro A, Parente D, Ambrosino C, Normanno N, Altucci L, Colantuoni V. Epigenetic silencing of Peroxisome Proliferator-Activated Receptor γ is a biomarker for colorectal cancer progression and adverse patients' outcome. PLoS One 2010, 5:e14229. 10.1371/journal.pone.0014229, 2997072, 21151932.
9. van Puijenbroek M, Nielsen M, Tops CM, Halfwerk H, Vasen HF, Weiss MM, van Wezel T, Hes FJ, Morreau H. Identification of patients with (atypical) MUTYH-associated polyposis by KRAS2 c.34G > T prescreening followed by MUTYH hotspot analysis in formalin-fixed paraffin-embedded tissue. Clin Cancer Res 2008, 14:139-142. 10.1158/1078-0432.CCR-07-1705, 18172263.
10. Donner LR, Wainwright LM, Zhang F, Biegel JA. Mutation of the INI1 gene in composite rhabdoid tumor of the endometrium. Hum Pathol 2007, 38:935-939. 10.1016/j.humpath.2006.12.003, 1963314, 17376508.
11. Lubbe SJ, Di Bernardo MC, Chandler IP, Houlston RS. Clinical implications of the colorectal cancer risk associated with MUTYH mutation. J Clin Oncol 2009, 24:3975-3980.
12. Issa JP. Colon Cancer: It's CIN or CIMP. Clin Cancer Res 2008, 14:5939-5940. 10.1158/1078-0432.CCR-08-1596, 18829469.
13. Leggett B, Whitehall V. Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology 2010, 138:2088-2100. 10.1053/j.gastro.2009.12.066, 20420948.
14. Pancione M, Remo A, Colantuoni V. Genetic and epigenetic events generate multiple pathways in colorectal cancer progression. Patholog Res Int 2012, 2012:509348. 3409552, 22888469.
15. McGregor DK, Wu TT, Rashid A, Luthra R, Hamilton SR. Reduced expression of cytokeratin 20 in colorectal carcinomas with high levels of microsatellite instability. Am J Surg Pathol 2004, 28:712-718. 10.1097/01.pas.0000126757.58474.12, 15166663.
16. Baba Y, Nosho K, Shima K, Freed E, Irahara N, Philips J, Meyerhardt JA, Hornick JL, Shivdasani RA, Fuchs CS, Ogino S. Relationship of CDX2 loss with molecular features and prognosis in colorectal cancer. Clin Cancer Res 2009, 15:4665-4673. 10.1158/1078-0432.CCR-09-0401, 2777758, 19584150.
17. El Demellawy D, Khalifa MA, Ismiil N, Wong S, Ghorab Z. Primary colorectal small cell carcinoma: a clinicopathological and immunohistochemical study of 10 cases. Diagn Pathol 2007, 2:35. 10.1186/1746-1596-2-35, 2034542, 17803816.
18. Dekanić A, Dintinjan RD, Budisavljević I, Pećanić S, Butorac M, Jonjić N. Strong nuclear EGFR expression in colorectal carcinomas is associated with cyclin-D1 but not with gene EGFR amplification. Diagn Pathol 2011, 6:108. 10.1186/1746-1596-6-108, 3225321, 22050898.
19. Hollmann TJ, Hornick JL. INI1-deficient tumors: diagnostic features and molecular genetics. Am J Surg Pathol 2011, 35:47-63.
20. Deng G, Bell I, Crawley S, Gum J, Terdiman JP, Allen BA, Truta B, Sleisenger MH, Kim YS. BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer. Clin Cancer Res 2004, 10:10191-10195.
21. Wong JJ, Hawkins NJ, Ward RL, Hitchins MP. Methylation of the 3p22 region encompassing MLH1 is representative of the CpG island methylator phenotype in colorectal cancer. Mod Pathol 2011, 24:396-411. 10.1038/modpathol.2010.212, 21102416.
22. Furukawa T, Konishi F, Masubuchi S, Shitoh K, Nagai H, Tsukamoto T. Densely Methylated MLH1 Promoter Correlates With Decreased mRNA Expression in Sporadic Colorectal Cancers. Genes Chromosomes Cancer 2002, 35:1-10. 10.1002/gcc.10100, 12203784.